NCT02212249
- Conditions
- Connective Tissue Diseases, Primary Raynaud Disease, Scleroderma, Systemic, +3 more
- Locations
-
- Grenoble University Hospital Grenoble, France
Clinical trial condition
Scleroderma, Systemic
Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.
452 public trials
124 recruiting studies
Scleroderma, Systemic trial results
NCT02050360
- Conditions
- Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +10 more
- Locations
-
- Clinical Investigation Center - Pharmacology Unit - University Hospital of Grenoble Grenoble, France
Completed
The CARRA Registry
NCT01697254
- Conditions
- Arthritis, Arthritis, Juvenile, Auto-inflammatory Disease, +37 more
- Locations
-
- Duke Clinical Research Institute Durham, North Carolina, United States
Completed
Scleroderma Lung Disease
NCT00004563
- Conditions
- Connective Tissue Diseases, Fibrosis, Lung Diseases, +9 more
- Locations
-
Not specified
- Conditions
- Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +24 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00043706
- Conditions
- Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +4 more
- Locations
-
- UCLA-Department of Medicine, Division of Rheumatology Los Angeles, California, United States
- Boston Medical Center Boston, Massachusetts, United States
- UMDNJ Scleroderma Program New Brunswick, New Jersey, United States
- University of Texas - Houston Medical School Houston, Texas, United States
NCT01474109
- Conditions
- Connective Tissue Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +7 more
- Locations
-
- University of Arizona Arthritis Center Tucson, Arizona, United States
- UCLA Medical School - Rheumatology Division Rehabilitation Center Los Angeles, California, United States
- Arthritis & Rheumatic Disease Specialties Aventura, Florida, United States
- Sarasota Arthritis Research Center Sarasota, Florida, United States
Completed
A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis
NCT00512902
- Conditions
- Alveolitis, Connective Tissue Diseases, Scleroderma, Systemic, +3 more
- Locations
-
- UCLA David Geffen School of Medicine, Division of Rheumatology Los Angeles, California, United States
NCT01813279
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
- Locations
-
- Assistance Publique Hopitaux de Marseille Marseille, France
NCT01487551
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
- Locations
-
- Berlin, Germany
- Cologne, Germany
- Erlangen, Germany
- Gothenburg, Sweden